SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-121842
Filing Date
2023-11-29
Accepted
2023-11-29 07:36:19
Documents
16
Period of Report
2023-11-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2331615d1_8k.htm   iXBRL 8-K 39011
2 EXHIBIT 10.1 tm2331615d1_ex10-1.htm EX-10.1 78785
3 EXHIBIT 99.1 tm2331615d1_ex99-1.htm EX-99.1 12298
7 GRAPHIC tm2331615d1_ex10-1img002.jpg GRAPHIC 24635
8 GRAPHIC tm2331615d1d1_ex99-1img001.jpg GRAPHIC 5826
  Complete submission text file 0001104659-23-121842.txt   375543

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA egrx-20231127.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20231127_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20231127_pre.xml EX-101.PRE 22357
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2331615d1_8k_htm.xml XML 3324
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 231448468
SIC: 2834 Pharmaceutical Preparations